Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06093789
Other study ID # PT-PADC
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date November 1, 2023
Est. completion date July 30, 2024

Study information

Verified date April 2024
Source Ondokuz Mayis University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In this study, we aimed to examine the association between personality traits and amount of anesthetic drug consumption,of the patients who will receive sedoanalgesia for the oocyte retrieval procedure. As well as determining the anxiety scores in the preoperative period, the time to reach the desired sedation level, hemodynamic parameters in the perioperative period, peripheral oxygen saturation, EtCO2 value, postoperative pain, postanesthetic recovery, analgesic drug need, unconscious movement, and patient satisfaction.


Description:

Different personality traits, anxiety disorders, depression, and somatoform disorders are frequently encountered in women with infertility problems. Although there are many studies evaluating the relationship of anxiety with variables such as hemodynamic parameters, need for anesthetic medication, recovery times, postoperative pain and analgesic requirements, the relationship between personality traits and these variables has not been investigated. In our study, considering that the anesthesia needs of these patients with a stressful negative factor such as infertility may be at different levels, preoperative evaluation of the patients with a personality questionnaire will provide better perioperative management, a better quality recovery and possibly a higher quality oocyte aspiration. In this study, it was aimed to investigate the amount of anesthetic agent consumption, recovery times, postoperative pain scores, analgesic requirements, involuntary movement, time to reach sufficient sedation depth, and patient satisfaction of patients thought to have sedation. All patients will fill out Personality Belief Scale-Short Form (PBQ-S1) and Beck Anxiety Scale one day before the procedure and they will be registered.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 90
Est. completion date July 30, 2024
Est. primary completion date March 30, 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - 18- 50 year-old elective patients who signed the informed consent form from ASA I-II patients scheduled for oocyte retrieval. - Patients with sufficient education and mental capacity to complete in assessment scales and questionnaires. - Patients without neurological disorders, psychological illnesses, or drug or alcohol abuse - Patients without stimulant drug and alcohol consumption - Absence of significant cardiovascular, respiratory, kidney or liver disease. Exclusion Criteria: - Psychiatric or neurological disorder - Psychiatric drug use or alcohol consumption - Pregnancy - Presence of severe cardiac, hepatic or cerebrovascular disease - History of allergy to local anesthetics or systemic opioids - History of chronic pain - Patients who are unable to evaluate scales and questionnaires

Study Design


Related Conditions & MeSH terms


Intervention

Other:
PBQ-S1
All patients will fill out Personality Belief Scale-Short Form (PBQ-S1) and Beck Anxiety Scale one day before the procedure and they will be registered.

Locations

Country Name City State
Turkey Ondokuz Mayis University Samsun Atakum

Sponsors (1)

Lead Sponsor Collaborator
Ondokuz Mayis University

Country where clinical trial is conducted

Turkey, 

References & Publications (3)

CLARIDGE GS, HERRINGTON RN. Sedation threshold, personality, and the theory of neurosis. J Ment Sci. 1960 Oct;106:1568-83. doi: 10.1192/bjp.106.445.1568. No abstract available. — View Citation

Lee SS, Kim HH, Park HJ. Are Histrionic Personality Traits Associated with Irritability during Conscious Sedation Endoscopy? Gastroenterol Res Pract. 2015;2015:702492. doi: 10.1155/2015/702492. Epub 2015 Apr 12. — View Citation

Maranets I, Kain ZN. Preoperative anxiety and intraoperative anesthetic requirements. Anesth Analg. 1999 Dec;89(6):1346-51. doi: 10.1097/00000539-199912000-00003. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Propofol consumption mg, from the beginning to the end of the transvaginal oocyte retrieval procedure from the beginning to the end of the transvaginal oocyte retrieval procedure)
Secondary Time until the Ramsey Sedation Score of 4 is reached The period elapsed after the patient is transported to the operating table and the sedation protocol begins. -The period of time starting with the propofol injection until the Ramsey Sedation Score of 4
Secondary Amount of propofol (mg) used until the required sedation depth is reached The amount of iv propofol administered until the Ramsey Sedation Score of 4 is obtained The period of time starting with the propofol injection until the Ramsey Sedation Score of 4
Secondary Systolic, diastolic and, mean Blood pressure (mm/Hg) It will be monitored and documented every 5 minutes during the procedure. every 5 minutes during the procedure
Secondary Heart rate (beats/min) It will be monitored and documented every 5 minutes during the procedure. every 5 minutes during the procedure.
Secondary Peripheral oxygen saturation (%) (%): It will be monitored and documented every 5 minutes during the procedure. every 5 minutes during the procedure
Secondary Number of Involuntary movement during the procedure The presence of involuntary movement will be documented during the procedure. during the procedure.
Secondary Postoperative pain (visual analog scale) Pain status will be evaluated based on visual analog scale (VAS) at rest and after movement.every 30-minute intervals for one hour in the recovery room. Each VAS is scores 0-10 (0=no pain, 10=unbearable pain) After the procedure,every 30 minutes up to 1 hour
Secondary Analgesic consumption The analgesic agents administered to the patients throughout the postoperative period will be documented. postoperatively up to 2 hours
Secondary Postoperative recovery time The time until the Modified Aldrete Score reaches 9 points will be determined. postoperatively up to 2 hours
Secondary The incidences of post-operative nausea and vomiting (PONV) the presence of nausea and vomiting will be recorded for 24 hours after procedure the time from the end of the procedure until discharge
Secondary Undesirable events and interventions Bradycardia, hypotension, airway obstruction, hypoxia will be documented throughout the perioperative phase with the intervention. time between start of procedure and discharge
See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A